BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 2419621)

  • 1. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
    Uchida A; Moore M
    Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
    Uchida A; Yanagawa E
    J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
    Uchida A; Micksche M
    J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of cytotoxic factor by human large granular lymphocytes during interaction with autologous tumor cells: lysis of fresh human tumor cells.
    Uchida A; Klein E
    J Natl Cancer Inst; 1988 Nov; 80(17):1398-403. PubMed ID: 3262773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NK cell cytotoxic factor against fresh human tumors.
    Uchida A; Fukata H
    Nat Immun; 1993; 12(4-5):267-78. PubMed ID: 8257831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphocyte cytotoxicity against autologous tumor cells and the effect of interferon-beta on their activities. (2) Evaluation of large granular lymphocytes (LGL)].
    Ezaki K; Ito N; Suzuki M; Maruyama F; Kojima H; Sobue R; Matsui T; Ino T; Hirano M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1246-51. PubMed ID: 3107477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
    Uchida A; Micksche M; Hoshino T
    Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
    Blanchard DK; Kavanagh JJ; Sinkovics JG; Cavanagh D; Hewitt SM; Djeu JY
    Cancer Res; 1988 Nov; 48(22):6321-7. PubMed ID: 2972357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
    Uchida A; Micksche M
    Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
    Uchida A
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. I. Proliferation of two distinct T-cell subsets.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1987 Aug; 40(2):165-70. PubMed ID: 2956198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.
    Warren HS
    J Immunol; 1984 Jun; 132(6):2888-94. PubMed ID: 6233364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.